DNA Methylation Profiling of Pediatric Ectomesenchymoma Supports Embryonal Rhabdomyosarcoma-Like Epigenetic Identity.
Chiara Caporalini, Gianluca Mattei, Anna Maria Buccoliero et al.
✦ AI-curated · Sources linked
Case in brief
This report details two cases of ectomesenchymoma, a rare pediatric tumor with both rhabdomyoblastic and neuroectodermal features. Genetic analysis revealed RAS-pathway mutations in both tumors. Notably, DNA methylation profiling indicated that ectomesenchymoma shares an epigenetic identity with embryonal rhabdomyosarcoma, suggesting a common myogenic program despite differing histological characteristics. The findings enhance diagnostic accuracy through RAS-pathway testing and methylation profiling.
Diagnostic / clinical pearl
Clinicians should consider the potential for ectomesenchymoma to exhibit an epigenetic profile similar to embryonal rhabdomyosarcoma, which may aid in accurate diagnosis.
Why it matters
The study underscores the importance of integrating genomic and methylation analyses in refining the diagnostic approach for rare pediatric tumors.